Goldman Sachs’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-420,462
| Closed | -$12.3M | – | 6909 |
|
|
2017
Q3 | $12.3M | Buy |
420,462
+379,197
| +919% | +$10.6M | ﹤0.01% | 2385 |
|
|
2017
Q2 | $1.08M | Sell |
41,265
-38,529
| -48% | -$947K | ﹤0.01% | 4383 |
|
|
2017
Q1 | $1.87M | Sell |
79,794
-31,084
| -28% | -$767K | ﹤0.01% | 3811 |
|
|
2016
Q4 | $2.79M | Buy |
110,878
+73,667
| +198% | +$1.86M | ﹤0.01% | 3539 |
|
|
2016
Q3 | $1.04M | Sell |
37,211
-115,021
| -76% | -$2.95M | ﹤0.01% | 4359 |
|
|
2016
Q2 | $3.75M | Sell |
152,232
-16,821
| -10% | -$417K | ﹤0.01% | 3100 |
|
|
2016
Q1 | $3.74M | Sell |
169,053
-16,884
| -9% | -$449K | ﹤0.01% | 2938 |
|
|
2015
Q4 | $6.51M | Sell |
185,937
-13,931
| -7% | -$436K | ﹤0.01% | 2592 |
|
|
2015
Q3 | $5.69M | Buy |
199,868
+172,182
| +622% | +$5.78M | ﹤0.01% | 2776 |
|
|
2015
Q2 | $922K | Sell |
27,686
-145,858
| -84% | -$4.48M | ﹤0.01% | 4611 |
|
|
2015
Q1 | $4.89M | Buy |
173,544
+160,403
| +1,221% | +$3.99M | ﹤0.01% | 2928 |
|
|
2014
Q4 | $272K | Sell |
13,141
-169,611
| -93% | -$4.03M | ﹤0.01% | 5888 |
|
|
2014
Q3 | $4.46M | Sell |
182,752
-12,273
| -6% | -$325K | ﹤0.01% | 3130 |
|
|
2014
Q2 | $5.58M | Sell |
195,025
-21,203
| -10% | -$590K | ﹤0.01% | 2923 |
|
|
2014
Q1 | $6.05M | Sell |
216,228
-65,905
| -23% | -$1.62M | ﹤0.01% | 2807 |
|
|
2013
Q4 | $6.07M | Buy |
282,133
+63,863
| +29% | +$1.16M | ﹤0.01% | 2862 |
|
|
2013
Q3 | $2.9M | Buy |
218,270
+107,043
| +96% | +$1.44M | ﹤0.01% | 3530 |
|
|
2013
Q2 | $1.54M | Buy |
+111,227
| New | +$1.58M | ﹤0.01% | 3970 |
|
Goldman Sachs's PMC Position: Q4 2017 in Review
Goldman Sachs sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 420,462 shares — an estimated $12.3M sold.
Goldman Sachs first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $12.3M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Goldman Sachs reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Goldman Sachs sold 420,462 PharMerica Corporation shares in Q4 2017, an estimated $12.3M.
- Goldman Sachs first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Goldman Sachs's PharMerica Corporation position peaked at $12.3M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.